Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model
NCT06417645
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Surgery
Interventions
DRUG:
fixed propofol infusion 15 mg/kg/h until 1% BSR (burst suppression ratio)
Sponsor
Universidad del Desarrollo
Collaborators
[object Object]